Zoledronic acid in women with postmenopausal osteoporosis

Trial Profile

Zoledronic acid in women with postmenopausal osteoporosis

Phase of Trial: Phase IV

Latest Information Update: 20 May 2014

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Adverse reactions
  • Most Recent Events

    • 20 May 2014 New trial record
    • 05 Apr 2014 Results presented at the 2014 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top